Log In
BCIQ
Print this Print this
 

MTI-SAM3

  Manage Alerts
Collapse Summary General Information
Company Molecular Templates Inc.
DescriptionRibosome-inhibiting toxin variant against an unidentified receptor on melanoma cells
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationMelanoma
Indication DetailsTreat melanoma
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today